Objectives: CTX-M extended-spectrum b-lactamases (ESBLs) are emerging worldwide. Fast and reliable detection techniques may become mandatory for implementing proper treatment and infection control measures. Here, a bla CTX-M -specific LightCycler real-time PCR (LC-PCR) assay based on hybridization probes was developed.
Introduction
Plasmid-encoded extended-spectrum b-lactamases (ESBLs) of the CTX-M type are reported increasingly worldwide in Gram-negative bacilli (GNB).
1,2 CTX-M now account for most of the ESBLs found in Enterobacteriaceae. More than 80 variants have been described and are divided into five groups based on amino acid sequence identity (groups CTX-M-1, -2, -8, -9 and -25), with different groups prevalent in different countries. ESBL-producing Enterobacteriaceae (ESBL-E) are mostly associated with urinary tract infections, but may also cause significant bloodstream infections, which result in increased hospital costs, length of stay and patient mortality. 3, 4 Therefore, optimal detection methods for these ESBLs are becoming a major health issue. MICs of expanded-spectrum cephalosporins (ESCs) for ESBL-E may be increased only slightly as compared with non-ESBL-E, thus leading to misidentification. 5, 6 A series of easy to carry out tests, mostly based on synergy between clavulanic acid and ESCs, are recommended, but their main pitfall is limited sensitivity, especially with cephalosporinase-producing bacteria, and the requirement for an overnight culture and a further 18 h culture for detection of synergy. 4, 7 Detection of ESBLs at the genetic level is a valuable alternative to the phenotype-based methods, it is independent of gene expression and relatively rapid, as compared with susceptibility testing and culture results. 3, 6 Several molecular techniques for TEM, SHV, GES-type and CTX-M ESBL detection have been described, and so far evaluated only on pure cultures. 8 -10 Here we sought to develop a LightCycler real-time PCR (LC-PCR) assay based on hybridization probes to detect CTX-M producers and to differentiate alleles belonging to the five phylogenetic groups directly from urine samples. Using this technique CTX-M-positive urine samples were accurately identified.
Materials and methods

Urine samples and microscopic examination
Over a 3 month period (15 November 2005 to 15 February 2006) urine samples that were positive for GNB were collected. An aliquot of 20 mL from each urine sample was immediately frozen to 2208C. Gram staining and microscopic reading were done systematically by examining 50 fields. The shapes and number of microorganisms and cells per oil immersion field were recorded. The presence of 1 microorganism uniformly distributed per field, after observation of at least 20 fields, was considered as positive for . 10 5 GNB/mL. 11 Leucocytes were manually counted using Kova slides (Hycor Biomedicals, Penıcuik, UK) and interpreted as recommended.
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Bacterial strains and microbiological techniques
Ten CTX-M producers were used as positive controls. 8 Eight Klebsiella oxytoca clinical isolates were also used as controls since they produce structurally related but chromosomally encoded ESBLs (KOXY/K1). 8 Escherichia coli DH10B was used as a CTX-M-negative control.
Bacterial identification and disc diffusion susceptibility testing were performed as described previously. 7 The presence of ESBLs was inferred by a synergy image using the double-disc synergy test as described previously. 7, 8 Nucleic acid extractions, standard PCR and DNA sequencing Whole-cell DNAs were extracted either from standard strains using the QIAamp DNA Mini Kit (Qiagen, Les Ulis, France) or from 106 urine samples positive for GNB according to Gram staining (36 ESBL-producing and 70 non-ESBL-producing Gram-negative isolates) using the QIAamp Viral RNA Mini Kit (Qiagen). PCR of the entire bla CTX-M-like , bla TEM-like and bla SHV-like genes, sequencing and sequence analysis were as previously described. 8 
Construction of the internal amplification control (IAC)
An IAC was constructed as described previously to monitor potential PCR inhibitors and ensure successful amplification. 12 The IAC, a 400 bp PCR fragment derived from pUC19 plasmid DNA, was used at 10 4 copies and was detected using two detection primers, pUC19-3i-fluo and pUC19-5i-Red610 (Table 1) .
LC-PCR
PCR primers CTX-M-A1 and CTX-M-A6 were designed to amplify a 444 bp fragment from all the bla CTX-M genes [ Table 1 and Figure S1 , available as Supplementary data at JAC Online (http:// jac.oxfordjournals.org/)]. All LC-PCRs were performed using the LightCycler system 2.0 (Roche Diagnostics, Meylan, France) in a final volume of 20 mL.
The LightCycler-FastStart DNA Master plus SYBR Green I Kit (Roche Diagnostics) was used for SYBR Green detection, with the following amplification protocol: 948C for 10 min; and 40 cycles consisting of 948C for 10 s, 578C for 10 s and 728C for 10 s; followed by a melting curve analysis. 8 Amplification of products was monitored at 530 nm. 8 The amplification mixture for LC-PCR with specific product detection (HYB-probe LC-PCR) consisted of 4 mL of reaction mixture (LC-FastStart master hybridization probes; Roche Diagnostics), 3 mM MgCl 2 , 0.8 mM of each amplification primer (Table 1) , 0.3 mM of each anchor and sensor probe (Table 1 and Figure S1 ), 5 mL of template DNA and 2 mL of the IAC in a final volume of 20 mL. Samples were amplified as follows: 958C for 10 min; and 40 cycles of 958C for 10 s, 508C for 10 s and 728C for 22 s. Positive samples were identified by the instrument at the cycle number (Ct) where the fluorescence rose above background. A melting curve analysis was then performed as recommended by the manufacturer. Samples with amplicons having melting temperatures at the correct temperature were scored as positive for the respective target genes.
Sensitivity of LC-PCR assays for CTX-M detection
To assess the sensitivity of the LC-PCR assays for detection of the bla CTX-M genes in urine samples, overnight cultures of five CTX-M-producing Enterobacteriaceae were diluted in ESBL-negative urine samples to yield final spiking levels of 10 0 -10 7 cfu/mL. DNA extracted from each dilution was tested by HYB-probe LC-PCR assay.
Results and discussion
ESBL-producing GNB (ESBL-GNB) in urine samples
Among the 5500 urine samples that were sent to the laboratory over the study period, 810 (from 655 different patients) were retained as being positive for GNB according to Gram staining results (e.g. containing at least 10 4 GNB/mL). Thirty-six (from 29 patients) contained ESBL-GNB according to synergy testing, thus yielding a prevalence of ESBL-GNB in urine samples of 4.4% (or 4.2% per patient) [ Table 2 and Table S1 , available as Supplementary data at JAC Online (http://jac.oxfordjournals. org/)]. ESBL prevalence in the urine samples increased by a factor of 3 in the last 5 years at Bicêtre hospital, similar to what has been observed in other hospitals/countries (Table 2) .
The ESBL-producing bacterial species were: E. coli (22/29, 77%); Klebsiella pneumoniae (2/29, 7%); Citrobacter freundii (2/29, 7%); Providencia stuartii (1/29, 3%); Enterobacter cloacae (1/29, 3%); and Enterobacter aerogenes (1/29, 3%). These isolates were also resistant to other non-b-lactam antibiotics used for treating urinary tract infections such as gentamicin (60%), co-trimoxazole (70%) and ciprofloxacin (90%), but remained susceptible to carbapenems (imipenem, ertapenem and meropenem). These isolates were mostly from patients in the nephrology (27%), emergency (24%), gerontology (17%) and urology (10%) departments. For 52% of the patients, a urinary tract infection was diagnosed upon admission to the hospital, most of the patients were elderly people (median age 68 years) and the sex ratio was 17 females to 12 males (Table S1 ).
LC-PCR detection of bla CTX-M genes in control strains
Fluorescence monitoring of product accumulation and detection by SYBR Green was used to test the amplification primers CTX-M-A1 and CTX-M-A6 on DNA extracted from pure CTX-M reference strains. Monitoring by gel electrophoresis revealed a single amplification product of high intensity and of the expected size (444 bp). No accumulation was observed with the negative controls, i.e. E. coli DH10B and Tris-EDTA solution (data not shown).
Similar results were obtained with HYB-probe LC-PCR hybridization probes, and the subsequent melting curve analysis monitored at the various wavelengths revealed single peaks for each bla CTX-M -type gene: bla CTX-M-1/3/15 , 638C at 705 nm; bla CTX-M-8 , 67.58C at 670 nm; bla CTX-M-2 , 49.58C at 640 nm; bla CTX-M-25 , 588C at 670 nm; and bla CTX-M-9/14/16/19 , 608C at 640 nm. HYB-probe detection was highly specific, since only CTX-M producers were detected and no cross-reactivity could be observed with K. oxytoca strains that produce a structurally related b-lactamase (KOXY). Similarly, no signal was obtained with E. coli isolates or Tris-EDTA solution as negative controls.
LC-PCR detection of CTX-M producers in urine samples
Detection limits of HYB-probe LC-PCR using the different hybridization probes on bacterial DNA extracted from artificially spiked urine samples were 10 2 -10 3 bacteria/mL of urine. Samples were run in triplicate, and the Ct values obtained in three different runs indicated that the LC-PCR assay was highly reproducible. Negative results were always validated by amplification of the IAC. Among the 70 ESBL-negative isolates, none gave positive PCR results.
HYB-probe LC-PCR detected in 25 out of the 36 ESBL-positive urines bla CTX-M genes that belonged to three of the five CTX-M clusters, i.e. 17 to CTX-M-1, 6 to CTX-M-9 and 2 to CTX-M-2. For a few patients, with repeated urine samples, reproducible identification of the same CTX-M type was achieved. Standard PCR followed by sequencing confirmed the HYB-probe LC-PCR results. Three different types of CTX-M enzymes were detected: CTX-M-15, n¼17; CTX-M-14, n¼6; and CTX-M-2, n¼2. In this study, CTX-M enzymes represented 66% (19/29) of the ESBLs and CTX-M-15 (13/19, 70%) was the predominant CTX-M-type b-lactamase. This situation mirrors the current trend observed in many hospitals worldwide.
1,2 The remaining 11 non-CTX-M ESBLs were 8 TEM types (TEM-3, TEM-21 and TEM-24) and 3 SHV types (SHV-2 and SHV-12) (Table S1 ).
Conclusions
Here, we show the technical feasibility of an LC-PCR detection assay used directly on urine samples. This technique is based on hybridization probes, conferring high specificity and sensitivity. Indeed, no false-positive results were obtained, and all the CTX-M-positive urine samples were detected repeatedly and CTX-M groups could be identified unambiguously. In the current epidemiological situation, one-third of the ESBLs were missed using this technique since TEM and SHV ESBLs were not detected. Thus, this assay should be coupled with another detection method geared towards TEM and SHV enzymes. Thus most if not all ESBLs would be detected.
The ease, speed and reliability of the LC-PCR technique makes it a powerful technique for detection of CTX-M producers. It may be used to control the emerging bla CTX-M resistance determinants, which are becoming a major public health issue.
